Skip to main content

Publications

featured publications

  • Inhibition of Fibroblast Growth Factor Receptor 3 Signaling by Ponatinib Reduces Growth and Cytokine Production of Multiple Myeloma Cells.

    International journal of molecular sciences

    Authors: Sascha Kampmann, Sebastian Schlaweck, Benjamin V Becker, Chrystel Flores, Annkristin Heine, Peter Brossart, Stefanie A E Held

  • Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinoma.

    Cancer treatment reviews

    Authors: Tessa Hattenhauer, Rebekka Mispelbaum, Franz-Georg Bauernfeind, Georg Feldmann, Dirk Baumjohann, Johannes Brägelmann, Annkristin Heine, Peter Brossart

  • Longer time to response in hemato-oncological patients with immune thrombocytopenia (ITP): a pilot study.

    Expert review of hematology

    Authors: Tessa Hattenhauer, Rebekka Mispelbaum, Peter Brossart, Carmen Kuehn, Annkristin Heine

  • Hypomethylating Agents and Venetoclax Based Triplets Targeting FLT3, IDH and KMT2A in Acute Myeloid Leukemia: Current Studies and Challenges of a Tailored Approach.

    Cancers

    Authors: Elisa Santambrogio, Alessia Castellino, Ernesta Audisio, Martin Schumacher, Georg Feldmann, Raheel Iftikhar, Peter Brossart, Semra Aydin

  • NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms.

    Nature communications

    Authors: Ruth-Miriam Koerber, Calvin Krollmann, Kevin Cieslak, Elisabeth Tregel, Maria L Saenz, Tim H Brümmendorf, Steffen Koschmieder, Martin Griesshammer, Ines Gütgemann, Conny K Baldauf, Thomas Fischer, Peter Brossart, Carl Christian Kolbe, Eicke Latz, Dominik Wolf, Lino L Teichmann

  • Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial.

    European journal of haematology

    Authors: Tim Richardson, Elias Mai, Ekaterina Menis, Axel Benner, Diana Tichy, Kaya Miah, Mathias Hänel, Britta Besemer, Amelie Boquoi, Igor Wolfgang Blau, Christian S Michel, Hans Walter Lindemann, Snjezana Janjetovic, Peter Brossart, Helga Bernhard, Peter Reimer, Hans Salwender, Dirk Hose, Anja Seckinger, Marc Raab, Hartmut Goldschmidt, Christof Scheid

  • Effective and safe use of immune checkpoint inhibitors for non-small cell lung cancer in people living with HIV.

    HIV medicine

    Authors: Rebekka Mispelbaum, Tessa Hattenhauer, Christian Hoffmann, Clara Lehmann, Franz-Georg Bauernfeind, Peter Brossart, Maximilian Christopeit, Winfried Alsdorf, Carsten Bokemeyer, Julian P Layer, Julia Roider, Marcus Hentrich, Malte Benedikt Monin

  • Sepsis and organ failure are the major risks for allogeneic transplant patients in the post- or late- engraftment phase admitted to the ICU.

    Hematology (Amsterdam, Netherlands)

    Authors: Michael Serries, Lisa Faßbender, Hannah Zenzen, Mario Heine, Tobias A W Holderried, Peter Brossart, Katjana Schwab

  • On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information.

    Frontiers in immunology

    Authors: Tessa Hattenhauer, Rebekka Mispelbaum, Annkristin Heine, Katjana Schwab, Peter Brossart, Niklas Klümper, Jonas Saal

  • Dexamethasone induced Dectin-1 activation enhances NLRP3 inflammasome activation.

    Frontiers in immunology

    Authors: Ruth-Miriam Koerber, Sebastian Oberbeck, Philipp Kotthoff, Solveig N Daecke, Peter Brossart, Stefanie A E Held